Page last updated: 2024-09-03

omega-n-methylarginine and Cirrhosis, Liver

omega-n-methylarginine has been researched along with Cirrhosis, Liver in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (15.38)	18.2507
2000's	8 (61.54)	29.6817
2010's	3 (23.08)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aagaard, NK; Bech, JN; Pedersen, EB; Pedersen, RS; Sorensen, TB; Vilstrup, H	1
Moeller, M; Pohl, S; Ripoll, C; Thonig, A; Zipprich, A	1
Arroyo, V; Fernández-Hernando, C; Fernández-Varo, G; Held, KF; Jiménez, W; Melgar-Lesmes, P; Morales-Ruiz, M; Pauta, M; Planas, AM; Ribera, J; Soria, G; Tudela, R; Tugues, S	1
Hayes, PC; Helmy, A; Jalan, R; Johnston, NR; Newby, DE; Webb, DJ	1
Jespersen, B; Schaffalitzky de Muckadell, OB; Skøtt, O; Thiesson, HC	1
Hayes, PC; Helmy, A; Jalan, R; Newby, DE; Webb, DJ	1
Cardenas, A	1
Chia, S; Cruden, NL; Dover, AR; Ferguson, JW; Hayes, PC; Newby, DE	1
Abraldes, JG; Groszmann, RJ; Haq, O; Iwakiri, Y; Loureiro-Silva, MR	1
Dillon, JF; Forrest, EH; Hayes, PC; Jones, AL; Walker, J	1
Boon, NA; Hayes, PC; Jalan, R; Masumori, S; Newby, DE; Webb, DJ	1
Barletta, G; Del Bene, R; Gentilini, P; La Villa, G; Laffi, G; Masini, E; Pantaleo, P; Perfetto, F; Tarquini, R; Vecchiarino, S; Vizzutti, F	1
Capponi, A; Giostra, E; Hadengue, A; Lang, U; Martin, PY; Niederberger, M; Spahr, L	1

Trials

3 trial(s) available for omega-n-methylarginine and Cirrhosis, Liver

Article	Year
Renal effects of NO-inhibition in patients with cirrhosis vs. healthy controls: a randomized placebo-controlled crossover study. Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34, Issue:2 Topics: Angiotensin II; Cross-Over Studies; Denmark; Edetic Acid; Glomerular Filtration Rate; Hemodynamics; Humans; Iodine Radioisotopes; Kidney; Liver Cirrhosis; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Renal Plasma Flow; Renin	2014
Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites. The American journal of gastroenterology, 2003, Volume: 98, Issue:1 Topics: Angiotensin II; Ascites; Enzyme Inhibitors; Female; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Renin; Sodium; Water	2003
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis. Hepatology (Baltimore, Md.), 2001, Volume: 34, Issue:1 Topics: Aged; Aldosterone; Blood Pressure; Cross-Over Studies; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension, Portal; Kidney; Liver Cirrhosis; Male; Mesenteric Artery, Superior; Middle Aged; Nitric Oxide Synthase; Nitrites; Norepinephrine; omega-N-Methylarginine; Placebos; Renin; Sodium; Vascular Resistance	2001

Other Studies

10 other study(ies) available for omega-n-methylarginine and Cirrhosis, Liver

Article	Year
Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis. PloS one, 2015, Volume: 10, Issue:3 Topics: Animals; Blotting, Western; Dose-Response Relationship, Drug; Hepatic Artery; Hypertension, Portal; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Liver Cirrhosis; Male; Methoxamine; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Perfusion; Rats, Wistar; Vascular Resistance; Vasodilation	2015
Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats. Gut, 2013, Volume: 62, Issue:1 Topics: Animals; Ascites; Biomarkers; Carbon Tetrachloride; Endothelial Cells; Endothelium, Lymphatic; Liver Cirrhosis; Lymphatic System; Lymphography; Male; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Random Allocation; Rats; Rats, Wistar	2013
Nitric oxide mediates the reduced vasoconstrictor response to angiotensin II in patients with preascitic cirrhosis. Journal of hepatology, 2003, Volume: 38, Issue:1 Topics: Angiotensin II; Ascites; Case-Control Studies; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Forearm; Humans; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents	2003
Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide. Gut, 2003, Volume: 52, Issue:3 Topics: Adult; Case-Control Studies; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Female; Forearm; Hemodynamics; Humans; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peptides, Cyclic; Plethysmography; Regional Blood Flow; Vasodilation	2003
Nitric oxide inhibition in cirrhosis and ascites. The American journal of gastroenterology, 2003, Volume: 98, Issue:7 Topics: Ascites; Enzyme Inhibitors; Humans; Liver Cirrhosis; Nitric Oxide; omega-N-Methylarginine	2003
Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites. Gut, 2006, Volume: 55, Issue:4 Topics: Ascites; Dose-Response Relationship, Drug; Female; Forearm; Hemodynamics; Humans; Infusions, Intra-Arterial; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide Synthase Type II; Norepinephrine; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Vasoconstriction	2006
Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat livers. Journal of hepatology, 2006, Volume: 44, Issue:5 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Enzyme Inhibitors; Liver Circulation; Liver Cirrhosis; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Vasodilation	2006
The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis. Journal of hepatology, 1995, Volume: 23, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Arginine; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Portal Pressure; Splanchnic Circulation; Thermography	1995
Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems. Cardiovascular research, 1998, Volume: 38, Issue:1 Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Female; Forearm; Humans; Liver Cirrhosis; Losartan; Male; Middle Aged; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Renin-Angiotensin System; Sympathetic Nervous System; Sympathomimetics; Vascular Resistance	1998
Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2002, Volume: 50, Issue:2 Topics: Adult; Aged; Aspartate Aminotransferases; Atrial Natriuretic Factor; Dinoprostone; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Inhibitors; Female; Hemodynamics; Humans; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Renal Circulation	2002